Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant”

4,945 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,945 results

Testing effectiveness (Phase 2)Looking for participantsNCT06178159
What this trial is testing

DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer

Who this might be right for
Breast Cancer
RemeGen Co., Ltd. 40
Post-approval studies (Phase 4)UnknownNCT05444673
What this trial is testing

A Prospective, Single-arm Clinical Study of Pabrolizumab in Combination With Cisplatin + 5-FU for the Neoadjuvant Treatment of Unresectable, Advanced Squamous Carcinoma of the Temporal Bone Single-arm Clinical Study

Who this might be right for
Temporal Bone Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30
Large-scale testing (Phase 3)Looking for participantsNCT06563869
What this trial is testing

Sintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital with Nanjing Medical University 40
Large-scale testing (Phase 3)Looking for participantsNCT06696794
What this trial is testing

Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients

Who this might be right for
Non-Muscle-Invasive Bladder Cancer (NMIBC)
Shaogang Wang 180
Large-scale testing (Phase 3)Looking for participantsNCT03417622
What this trial is testing

Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy

Who this might be right for
Breast Cancer
Mansoura University 370
Not applicableActive Not RecruitingNCT06421142
What this trial is testing

FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer

Who this might be right for
Urinary Bladder Neoplasms
First Affiliated Hospital of Fujian Medical University 80
Not applicableActive Not RecruitingNCT05181488
What this trial is testing

Intraoperative Radiation Therapy for Resectable Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Cancer
Yona Cho 80
Not applicableLooking for participantsNCT07327970
What this trial is testing

Prospective Validation of Ataraxis AI Test for Predicting Treatment Response in Neoadjuvant Breast Cancer

Who this might be right for
Breast Cancer
Young-Joon Kang 150
Very early researchActive Not RecruitingNCT06853769
What this trial is testing

Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University 48
Large-scale testing (Phase 3)Study completedNCT03996369
What this trial is testing

Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Arena Pharmaceuticals 354
Testing effectiveness (Phase 2)Active Not RecruitingNCT04776590
What this trial is testing

Chemoradiotherapy Plus Immunotherapy Followed by Surgery for Esophageal Cancer

Who this might be right for
Esophagus CancerNeoadjuvant Therapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Very early researchLooking for participantsNCT04741997
What this trial is testing

Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVBRAF V600 Mutation
H. Lee Moffitt Cancer Center and Research Institute 50
Testing effectiveness (Phase 2)WithdrawnNCT06881823
What this trial is testing

Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive HRLPC

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT00126659
What this trial is testing

Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 10
Large-scale testing (Phase 3)UnknownNCT01534546
What this trial is testing

Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection

Who this might be right for
Advanced Gastric Carcinoma
Peking University 1,094
Not applicableNot Yet RecruitingNCT06616870
What this trial is testing

Study of the Predictive and Prognostic Role of Pharmacogenetic and Radiogenic Variants on the Response to Neoadjuvant Chemoradiation Therapy in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Centro di Riferimento Oncologico - Aviano 460
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07515469
What this trial is testing

A Prospective, Single-Arm, Exploratory Study of the Safety and Efficacy of Neoadjuvant Treatment With QL1706, an Anti-PD-1/Anti-CTLA-4 Bispecific Antibody, in Resectable Stage IB and IIA Hepatocellular Carcinoma With High Recurrence Risk

Who this might be right for
HCC - Hepatocellular CarcinomaIparomlimab and Tuvonralimab InjectionNeoadjuvant Immunotherapy
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableStudy completedNCT00706641
What this trial is testing

Neoadjuvant Dasatinib and Radical Cystectomy for Transitional Cell Carcinoma of the Bladder

Who this might be right for
Transitional Cell Carcinoma of the Bladder
Hoosier Cancer Research Network 25
Testing effectiveness (Phase 2)Looking for participantsNCT06401005
What this trial is testing

SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC)

Who this might be right for
Breast Cancer
Hubei Cancer Hospital 51
Not applicableUnknownNCT04362462
What this trial is testing

Molecular Profiling After Neoadjuvant Chemotherapy for Triple-negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Texas Tech University Health Sciences Center, El Paso 120
Load More Results